Corient Private Wealth
GDRX icon

Corient Private Wealth’s GoodRx Holdings GDRX Stock Holding History

Corient Private Wealth’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.1K Buy
+29,902
New +$76K ﹤0.01% 2953

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Corient Private Wealth's GDRX Position: Q2 2026 in Review

Corient Private Wealth opened a new position in GoodRx Holdings (GDRX) in Q2 2026: 29,902 shares worth $86.1K. The stake represents ﹤0.01% of the portfolio and ranks #2953 among its holdings.

162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Corient Private Wealth held 29,902 shares of GoodRx Holdings worth $86.1K as of Q2 2026.
  • GoodRx Holdings was a new Corient Private Wealth position in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2953 holding.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.